[go: up one dir, main page]

PE20030130A1 - Procedimientos para la preparacion de bromuro de tiotropio cristalino anhidro - Google Patents

Procedimientos para la preparacion de bromuro de tiotropio cristalino anhidro

Info

Publication number
PE20030130A1
PE20030130A1 PE2002000538A PE2002000538A PE20030130A1 PE 20030130 A1 PE20030130 A1 PE 20030130A1 PE 2002000538 A PE2002000538 A PE 2002000538A PE 2002000538 A PE2002000538 A PE 2002000538A PE 20030130 A1 PE20030130 A1 PE 20030130A1
Authority
PE
Peru
Prior art keywords
bromide
tiotrope
preparation
procedures
anhydrous
Prior art date
Application number
PE2002000538A
Other languages
English (en)
Inventor
Peter Sieger
Ulrike Werthmann
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PE20030130A1 publication Critical patent/PE20030130A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

SE REFIERE AL BROMURO DE TIOTROPIO CRISTALINO ANHIDRO CARACTERIZADO POR UNA CELDA ELEMENTAL MONOCLINICA DETERMINADA MEDIANTE ANALISIS ESTRUCTURAL DE RAYOS X CON LOS PARAMETROS a=10,4336(2)A, b= 11,3297(3)A, c=17,6332(4)A Y O=90°, ß=105,158(2)° Y y=90° (VOLUMEN DE CELDA=2011,89(8)A. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION DE BROMURO DE TIOTROPIO ANHIDRO MEDIANTE UNA DESECACION A MAS DE 50°C BAJO PRESION REDUCIDA DURANTE UN PERIODO DE TIEMPO DE 15 MINUTOS A 24 HORAS. SE PREPARA POR ALMACENAMIENTO DE MONOHIDRATO DE BROMURO DE TIOTROPIO CRISTALINO SOBRE UN AGENTE DE DESECACION APROPIADO DURANTE UN PERIODO DE 12 A 96 HORAS. EL BROMURO DE TIOTROPIO ES UN AGENTE ANTICOLINERGICO Y ES UTIL PARA EL TRATAMIENTO DE ASMA Y EPOC
PE2002000538A 2001-06-22 2002-06-21 Procedimientos para la preparacion de bromuro de tiotropio cristalino anhidro PE20030130A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10129710 2001-06-22
DE10215436 2002-04-08

Publications (1)

Publication Number Publication Date
PE20030130A1 true PE20030130A1 (es) 2003-04-02

Family

ID=26009556

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2002000538A PE20030130A1 (es) 2001-06-22 2002-06-21 Procedimientos para la preparacion de bromuro de tiotropio cristalino anhidro
PE2007000660A PE20081305A1 (es) 2001-06-22 2002-06-21 Bromuro de tiotropio cristalino anhidrido como agente anticolinergico y procedimiento para la preparacion de un medicamento

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2007000660A PE20081305A1 (es) 2001-06-22 2002-06-21 Bromuro de tiotropio cristalino anhidrido como agente anticolinergico y procedimiento para la preparacion de un medicamento

Country Status (37)

Country Link
EP (1) EP1401445B1 (es)
JP (1) JP2005504015A (es)
KR (2) KR101011353B1 (es)
CN (1) CN100586948C (es)
AR (1) AR037491A1 (es)
AT (1) ATE337006T1 (es)
AU (1) AU2002345016B2 (es)
BG (1) BG66303B1 (es)
BR (1) BR0210537A (es)
CA (1) CA2450961C (es)
CO (1) CO5550423A2 (es)
CY (1) CY1105223T1 (es)
CZ (1) CZ302786B6 (es)
DE (1) DE50207943D1 (es)
DK (1) DK1401445T3 (es)
EA (1) EA005813B1 (es)
EE (1) EE05316B1 (es)
EG (1) EG24851A (es)
ES (1) ES2271280T3 (es)
HR (1) HRP20031066B1 (es)
HU (1) HUP0400333A3 (es)
IL (2) IL159238A0 (es)
ME (1) ME00412B (es)
MX (1) MXPA03011718A (es)
MY (1) MY122779A (es)
NO (1) NO334301B1 (es)
NZ (1) NZ530690A (es)
PE (2) PE20030130A1 (es)
PL (1) PL208137B1 (es)
PT (1) PT1401445E (es)
RS (1) RS50441B (es)
SA (1) SA02230255B1 (es)
SI (1) SI1401445T1 (es)
SK (1) SK287262B6 (es)
TW (2) TW200617007A (es)
UY (1) UY27342A1 (es)
WO (1) WO2003000265A1 (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
PE20050996A1 (es) * 2003-11-03 2005-12-20 Boehringer Ingelheim Int Nuevo anhidrato cristalino con accion anticolinergica
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
DK1781298T3 (da) 2004-04-22 2012-05-07 Boehringer Ingelheim Int Lægemiddelkombinationer indeholdende benzoxazin til behandling af luftvejs-sygdomme
DE102004024454A1 (de) 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2322148T3 (es) 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
WO2006111549A1 (de) 2005-04-21 2006-10-26 Boehringer Ingelheim International Gmbh Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
MX2007012907A (es) 2005-04-28 2008-03-14 Boehringer Ingelheim Int Nuevos compuestos para el tratamiento de enfermedades inflamatorias.
CA2606549A1 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
CA2606552A1 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
MX2008001976A (es) 2005-08-15 2008-03-25 Boehringer Ingelheim Int Procedimiento para la preparacion de betamimeticos.
US20070086957A1 (en) * 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
TW200732340A (en) * 2005-12-19 2007-09-01 Sicor Inc Novel forms of tiotropium bromide and processes for preparation thereof
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
CN100999521B (zh) * 2006-01-13 2010-12-08 江苏正大天晴药业股份有限公司 结晶性抗胆碱药噻托溴铵
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
ES2360963T3 (es) 2006-08-07 2011-06-10 Boehringer Ingelheim International Gmbh Combinaciones de fármacos para el tratamiento de enfermedades de las vías respiratorias.
UY30550A1 (es) 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
JP5150728B2 (ja) 2007-10-19 2013-02-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ピペリジノ−ジヒドロチエノピリミジン
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
CN103724328B (zh) 2008-12-19 2015-10-14 贝林格尔.英格海姆国际有限公司 作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺
EP2403851B1 (en) 2009-03-06 2015-06-17 Mahmut Bilgic New crystalline forms of tiotropium bromide
PL2513093T3 (pl) 2009-12-17 2015-03-31 Centrexion Therapeutics Corp Nowi antagoniści receptora CCR2 i ich zastosowanie
US20130143905A1 (en) 2009-12-17 2013-06-06 Boehringer Ingelheim International Gmbh Novel antagonists for ccr2 and uses thereof
EA201201052A1 (ru) 2010-01-29 2013-02-28 Бёрингер Ингельхайм Интернациональ Гмбх Замещенные нафтиридины и их применение в качестве ингибиторов киназы syk
EP2569295B1 (en) 2010-05-12 2014-11-19 Boehringer Ingelheim International GmbH New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP2013526507A (ja) 2010-05-12 2013-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ccr2受容体アンタゴニスト、その製造方法及び薬物としてのその使用
US8841313B2 (en) 2010-05-17 2014-09-23 Boehringer Ingelheim International Gmbh CCR2 antagonists and uses thereof
JP5636094B2 (ja) 2010-05-25 2014-12-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ccr2受容体アンタゴニスト
EP2576538B1 (en) 2010-06-01 2015-10-28 Boehringer Ingelheim International GmbH New CCR2 antagonists
TR201007108A2 (tr) * 2010-08-25 2012-03-21 B�Lg�� Mahmut Yeni tiotropyum bromür kristali ve üretim yöntemi.@
JP5959537B2 (ja) 2011-01-28 2016-08-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ピリジニル−ピリミジン及び医薬としてのその使用
TR201101897A2 (tr) 2011-02-28 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal madde
TR201102068A2 (tr) 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal maddeler
TR201111589A2 (tr) * 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür susuz kristal formu.
WO2012171863A1 (en) 2011-06-16 2012-12-20 Boehringer Ingelheim International Gmbh New selective ccr2 antagonists
WO2013010839A1 (en) 2011-07-15 2013-01-24 Boehringer Ingelheim International Gmbh Novel and selective ccr2 antagonists
PH12014500209A1 (en) 2011-07-26 2014-03-03 Boehringer Ingelheim Int Substituted quinolines and their use as medicaments
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
BR112014012414B1 (pt) 2011-11-25 2022-01-11 Adverio Pharma Gmbh Processos para preparar 5-flúor-1h-pirazolopiridinas substituídas
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
PT106142B (pt) * 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
US9096579B2 (en) 2012-04-20 2015-08-04 Boehringer Ingelheim International Gmbh Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
EP2897955B1 (en) * 2012-09-11 2019-11-06 Bilgic, Mahmut New tiotropium bromide crystalline form
EA025960B1 (ru) 2012-11-05 2017-02-28 Зентива, К.С. Стабилизация сольватов тиотропия
CN104341412A (zh) * 2013-07-29 2015-02-11 天津金耀集团有限公司 一种无水噻托溴铵结晶的制备方法
EP3119766B1 (en) 2014-03-19 2019-05-22 Boehringer Ingelheim International GmbH Heteroaryl syk inhibitors
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
HRP20201343T1 (hr) 2014-10-21 2020-11-27 Ariad Pharmaceuticals, Inc. Kristalni oblici 5-kloro-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidin-2,4-diamina
WO2017138896A1 (en) * 2016-02-11 2017-08-17 Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti Crystalline form of tiotropium bromide anhydrate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
CA2425539C (en) * 2000-10-12 2007-04-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums

Also Published As

Publication number Publication date
BG66303B1 (bg) 2013-03-29
TW200617007A (en) 2006-06-01
NZ530690A (en) 2005-05-27
EA200301293A1 (ru) 2004-08-26
CO5550423A2 (es) 2005-08-31
CZ2004120A3 (cs) 2004-05-12
AR037491A1 (es) 2004-11-17
NO20035696D0 (no) 2003-12-19
MXPA03011718A (es) 2004-12-06
SK287262B6 (sk) 2010-04-07
IL159238A (en) 2010-04-15
HK1068540A1 (zh) 2005-04-29
KR101011353B1 (ko) 2011-01-28
NO334301B1 (no) 2014-02-03
PL208137B1 (pl) 2011-03-31
ES2271280T3 (es) 2007-04-16
BR0210537A (pt) 2004-06-22
ME00412B (me) 2011-10-10
HUP0400333A2 (hu) 2004-12-28
UY27342A1 (es) 2003-02-28
DK1401445T3 (da) 2006-11-27
BG108440A (bg) 2004-08-31
ATE337006T1 (de) 2006-09-15
HRP20031066A2 (en) 2004-04-30
CA2450961C (en) 2010-03-30
SA02230255B1 (ar) 2006-10-31
IL159238A0 (en) 2004-06-01
KR100971616B1 (ko) 2010-07-22
PT1401445E (pt) 2006-10-31
SK522004A3 (en) 2004-06-08
DE50207943D1 (de) 2006-10-05
KR20090031638A (ko) 2009-03-26
JP2005504015A (ja) 2005-02-10
EE05316B1 (et) 2010-08-16
PL364489A1 (en) 2004-12-13
AU2002345016B2 (en) 2008-04-17
SI1401445T1 (sl) 2007-02-28
EP1401445B1 (de) 2006-08-23
YU99703A (sh) 2006-05-25
HUP0400333A3 (en) 2012-10-29
CZ302786B6 (cs) 2011-11-09
KR20040018285A (ko) 2004-03-02
HRP20031066B1 (en) 2011-10-31
PE20081305A1 (es) 2008-10-01
CN100586948C (zh) 2010-02-03
RS50441B (sr) 2010-03-02
EG24851A (en) 2010-10-27
CA2450961A1 (en) 2003-01-03
WO2003000265A1 (de) 2003-01-03
EE200400029A (et) 2004-04-15
MY122779A (en) 2006-05-31
TWI261589B (en) 2006-09-11
CN1520294A (zh) 2004-08-11
MEP62008A (en) 2011-05-10
EA005813B1 (ru) 2005-06-30
CY1105223T1 (el) 2010-03-03
EP1401445A1 (de) 2004-03-31

Similar Documents

Publication Publication Date Title
PE20030130A1 (es) Procedimientos para la preparacion de bromuro de tiotropio cristalino anhidro
CA2538225A1 (en) Device and method for wound therapy
CO5580827A2 (es) Forma polimorfa de rimonabant, su procedimiento de preparacion y composiciones farmaceuticas que la contienen
CL2010001207A1 (es) Traje de salvamento para naufragios para alojar el cuerpo del naufrago en su interior, con capacidad de flotacion, comprende un receptaculo delimitado por al menos una cubierta interior y una cuebierta exterior separadas entre si por una camara de aire hermetica; una manga cabezal desplegable y manga exterior como cubierta cabezal.
PE20080867A1 (es) Procedimiento de preparacion de halogenuros de n-alquil-naltrexona
PE20020422A1 (es) MONOHIDRATO CRISTALINO DEL BROMURO DE (1a,2ß,4ß,5a,7ß)-7-[(HIDROXI-DI-2-TIENIL-ACETIL)OXI]-9,9-DIMETIL-3-OXA-9-AZONIA-TRICICLO[3.3.1.02,4] NONANO
PE20030824A1 (es) Formulacion superfina de formoterol
EP1555705A3 (en) Cathode active material for lithium rechargeable battery and lithium rechargeable battery using the same
PE20050996A1 (es) Nuevo anhidrato cristalino con accion anticolinergica
AR071592A1 (es) Fenoxibenzamidas sustituidas
KR20200055023A (ko) 이산화염소 가스의 발생 방법, 액체 조성물, 겔상 조성물 및 이산화염소 가스 발생 키트
ES2040217T3 (es) Procedimiento para preparar derivados de acido flavona-carboxilico.
AR061237A2 (es) Metodo y disposicion de almohadilla para tomar rayos x
ATE273033T1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
ECSP034570A (es) Formulacion de una solucion de inhalacion con una sal tiotropio
RU2012154006A (ru) Кристаллическая форма гликопиррония хлорида
PE20030092A1 (es) Formulacion de una solucion de inhalacion con una sal de tiotropio
ES2262459T1 (es) Nuevas formas cristalinas de atorvastatina semicalcica y procedimientos para su preparacion.
JP6433007B1 (ja) 二酸化塩素ガスの発生方法、液性組成物、ゲル状組成物、及び二酸化塩素ガス発生キット
GT199800198A (es) Formatermodinamicamenteestabledelacido(r)-3-[[(4-fluorofenil)sulfonil]amino]-1,2,3,4-tetrahidro-9h-carbazol-9-propanoico(ramatroban ).
CN221655490U (zh) 一种急救氧气袋
CN219126652U (zh) 一种防松脱手用种植持钉器
CN203634126U (zh) 一种新型深喉喉镜叶片
ES2267421T1 (es) Procedimiento para la preparacion de acido (6rs)-n(5)-formil-5,6,7,8-tetrahidrofolico cristalino.
CN222723066U (zh) 一种便携式气腹机

Legal Events

Date Code Title Description
FG Grant, registration